Ziopharm Appoints Kevin Boyle as Their New CEO
Here is a brief preview of this blast: On Monday, August 30, Ziopharm announced (press release / webcast) the appointment of Kevin Boyle as their new CEO, with Heidi Hagen (interim CEO) returning to her position on the Board of Directors. Below, Celltelligence provides insights on how Boyle could help improve Ziopharm’s financial situation while regaining shareholders' confidence.